← Eichor
Condition: Sickle Cell Disease Vaso Occlusive Crisis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Sickle Cell Disease Vaso Occlusive Crisis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07001631Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis
NA · 2 location(s) · Imam Abdulrahman Bin Faisal University · NCT07188766Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Phase 2 · 5 location(s) · CSL Behring · NCT07224360Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
Phase 3 · 11 location(s) · Nantes University Hospital · NCT07274254Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Phase 2 · 1 location(s) · Mohsen Saidinejad · NCT07369024High-flow Oxygen for Vaso-occlusive Pain Crisis
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03976180Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Phase 4 · 31 location(s) · Novartis Pharmaceuticals · NCT04657822Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Cr
NA · 1 location(s) · University of Maryland, Baltimore · NCT06184126Sickle Cell Improvement: Enhancing Care in the Emergency Department
NA · 1 location(s) · Medical College of Wisconsin · NCT05373771Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07001189Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Phase 2 · 1 location(s) · Suvankar Majumdar · NCT06635902Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusiv
Phase 2 · 19 location(s) · CSL Behring · NCT06699849PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
Phase 1 · 1 location(s) · Enrico Novelli · NCT04925492Exploratory Study on Global Reflexology in Sickle Cell Disease
NA · 1 location(s) · Hospices Civils de Lyon · NCT06619197Oral Ketamine for Treatment of Vaso-Occlusive Pain
Phase 3 · 1 location(s) · Boston Children's Hospital · NCT05378555Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06399107A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult
Phase 3 · 32 location(s) · Novartis Pharmaceuticals · NCT06439082Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NA · 6 location(s) · University Hospital, Tours · NCT07246265Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carryi
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07432867Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
Phase N/A · 1 location(s) · BILLOIR · NCT05376046Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
NA · 2 location(s) · St. Jude Children's Research Hospital · NCT03353584
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.